4/9
09:08 am
CUE
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Medium
Report
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
4/9
09:08 am
CUE
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Medium
Report
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
4/9
08:45 am
CUE
Rating for CUE
Medium
Report
Rating for CUE
4/9
08:44 am
CUE
Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
Low
Report
Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.
4/9
08:20 am
CUE
Rating for CUE
Low
Report
Rating for CUE
4/9
08:20 am
CUE
Rating for CUE
Low
Report
Rating for CUE
3/13
09:00 am
CUE
Rating for CUE
Medium
Report
Rating for CUE
3/13
09:00 am
CUE
Rating for CUE
Medium
Report
Rating for CUE